Log in to save to my catalogue

Dexamethasone attenuates development of monocrotaline-induced pulmonary arterial hypertension

Dexamethasone attenuates development of monocrotaline-induced pulmonary arterial hypertension

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_864196678

Dexamethasone attenuates development of monocrotaline-induced pulmonary arterial hypertension

About this item

Full title

Dexamethasone attenuates development of monocrotaline-induced pulmonary arterial hypertension

Publisher

Dordrecht: Dordrecht : Springer Netherlands

Journal title

Molecular biology reports, 2011-06, Vol.38 (5), p.3277-3284

Language

English

Formats

Publication information

Publisher

Dordrecht: Dordrecht : Springer Netherlands

More information

Scope and Contents

Contents

Immunity and inflammation are well established factors in the pathogenesis of pulmonary arterial hypertension (PAH). We aimed to investigate whether dexamethasone (Dex), a potent immunosuppressant, could prevent the development of monocrotaline (MCT)-induced PAH in rats as compared with pyrrolidine dithiocarbamate (PDTC) and its effect on the immun...

Alternative Titles

Full title

Dexamethasone attenuates development of monocrotaline-induced pulmonary arterial hypertension

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_864196678

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_864196678

Other Identifiers

ISSN

0301-4851

E-ISSN

1573-4978

DOI

10.1007/s11033-010-0390-x

How to access this item